Spectrum Health participates in the HEALEY ALS Platform Trial, the first of its kind for ALS, speaking today with Dr. Paul Twydell, Spectrum Health's Director of Neuromuscular Medicine.
Spectrum Health
Facebook Twitter LinkedIn Email
Your browser doesn’t support HTML5 audio